Literature DB >> 12791935

Algorithm specification interface for human immunodeficiency virus type 1 genotypic interpretation.

Bradley J Betts, Robert W Shafer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12791935      PMCID： PMC156534          DOI： 10.1128/JCM.41.6.2792-2794.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  8 in total

1.  HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.

Authors:  Jaideep Ravela; Bradley J Betts; Francoise Brun-Vézinet; Anne-Mieke Vandamme; Diane Descamps; Kristel van Laethem; Kate Smith; Jonathan M Schapiro; Dean L Winslow; Caroline Reid; Robert W Shafer
Journal:  J Acquir Immune Defic Syndr       Date:  2003-05-01       Impact factor: 3.731

2.  Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.

Authors:  G H Kijak; A E Rubio; S E Pampuro; C Zala; P Cahn; R Galli; J S Montaner; H Salomón
Journal:  HIV Med       Date:  2003-01       Impact factor: 3.180

3.  A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.

Authors:  Kristel Van Laethem; Andrea De Luca; Andrea Antinori; Antonella Cingolani; Carlo Federico Perna; Anne-Mieke Vandamme
Journal:  Antivir Ther       Date:  2002-06

4.  Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

Authors:  Jean-Luc Meynard; Muriel Vray; Laurence Morand-Joubert; Esther Race; Diane Descamps; Gilles Peytavin; Sophie Matheron; Claire Lamotte; Sonia Guiramand; Dominique Costagliola; Françoise Brun-Vézinet; François Clavel; Pierre-Marie Girard
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

5.  Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy.

Authors:  M N Rousseau; L Vergne; B Montes; M Peeters; J Reynes; E Delaporte; M Segondy
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

6.  Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database.

Authors:  R W Shafer; D Stevenson; B Chan
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

7.  Comparison of virtual phenotype and HIV-SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains.

Authors:  E Puchhammer-Stöckl; C Steininger; E Geringer; F X Heinz
Journal:  HIV Med       Date:  2002-07       Impact factor: 3.180

8.  The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.

Authors:  V DeGruttola; L Dix; R D'Aquila; D Holder; A Phillips; M Ait-Khaled; J Baxter; P Clevenbergh; S Hammer; R Harrigan; D Katzenstein; R Lanier; M Miller; M Para; S Yerly; A Zolopa; J Murray; A Patick; V Miller; S Castillo; L Pedneault; J Mellors
Journal:  Antivir Ther       Date:  2000-03
  8 in total
  4 in total

1.  Phenotypic analysis of HIV-1 genotypic drug-resistant isolates from China, using a single-cycle system.

Authors:  Zheng Jia; Sihong Xu; Jianhui Nie; Jingyun Li; Ping Zhong; Wenbo Wang; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

Review 2.  The HIVdb system for HIV-1 genotypic resistance interpretation.

Authors:  Michele W Tang; Tommy F Liu; Robert W Shafer
Journal:  Intervirology       Date:  2012-01-24       Impact factor: 1.763

3.  Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.

Authors:  Joke Snoeck; Rami Kantor; Robert W Shafer; Kristel Van Laethem; Koen Deforche; Ana Patricia Carvalho; Brian Wynhoven; Marcelo A Soares; Patricia Cane; John Clarke; Candice Pillay; Sunee Sirivichayakul; Koya Ariyoshi; Africa Holguin; Hagit Rudich; Rosangela Rodrigues; Maria Belen Bouzas; Françoise Brun-Vézinet; Caroline Reid; Pedro Cahn; Luis Fernando Brigido; Zehava Grossman; Vincent Soriano; Wataru Sugiura; Praphan Phanuphak; Lynn Morris; Jonathan Weber; Deenan Pillay; Amilcar Tanuri; Richard P Harrigan; Ricardo Camacho; Jonathan M Schapiro; David Katzenstein; Anne-Mieke Vandamme
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  An Evolutionary Model-Based Approach To Quantify the Genetic Barrier to Drug Resistance in Fast-Evolving Viruses and Its Application to HIV-1 Subtypes and Integrase Inhibitors.

Authors:  Kristof Theys; Pieter J K Libin; Kristel Van Laethem; Ana B Abecasis
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.